近日,来自空军医科大学的研究者们在Theranostics杂志上发表了题为“Targeting β-catenin and PD-L1 simultaneously by a racemic supramolecular peptide for the potent immunotherapy of hepatocellular carcinoma”的文章,该研究揭示了超分子多肽同时靶向β-Catenin和PD-L1治疗肝细胞癌。
Zhengjun Zhou et al. Targeting β-catenin and PD-L1 simultaneously by a racemic supramolecular peptide for the potent immunotherapy of hepatocellular carcinoma. Theranostics. 2023 Jun 4;13(10):3371-3386. doi: 10.7150/thno.83377.